Adviser

Lucid.

Fairness opinion, Financial adviser on 5 live deals, from 28 Apr 2025 to 3 Dec 2025.

05Live deals
03Other advisers
01

Deals

DateDealStageRoleSector
3 Dec 2025Hyperliquid Strategies Inc / Sonnet BioTherapeutics Holdings, Inc.Closed
  • Fairness opinion to the targetSource-verified
Not stated
27 Oct 2025Biossil Inc. / Galera Therapeutics, Inc.Agreement signed
  • Fairness opinion to the targetSource-verified
Not stated
20 Aug 2025XOMA Royalty Corporation / Mural Oncology plcAgreement signed
  • Fairness opinion to the targetSource-verified
Healthcare
20 Aug 2025XRA 5 Corp. / MuralAgreement signed
  • Financial adviser to the targetSource-verified
Healthcare
28 Apr 2025Crescent / GlycoMimetics, Inc.Agreement signed
  • Financial adviser to the targetSource-verified
Not stated
02

By year, sector and stage

20255
Not stated3
Healthcare2
Agreement signed4
Closed1
03

Other advisers on the same deals

AdviserShared dealsAcross the tableAlongside
Lucid Capital Markets, LLC202
Lowenstein Sandler LLP101
Scheme Shareholders101